Anthracyclines News and Research

RSS
Caris Life Sciences study may have potentially significant benefit in patients with uterine cancer

Caris Life Sciences study may have potentially significant benefit in patients with uterine cancer

Research: New molecule safeguards heart from toxic breast cancer drugs, kills cancerous tumour

Research: New molecule safeguards heart from toxic breast cancer drugs, kills cancerous tumour

Study sheds light on clinical and biological characteristics of male breast cancer

Study sheds light on clinical and biological characteristics of male breast cancer

Combination therapy benefits patients with acute myeloid leukemia

Combination therapy benefits patients with acute myeloid leukemia

Eribulin drug has minor added benefit in one patient group, indication of lesser benefit in others

Eribulin drug has minor added benefit in one patient group, indication of lesser benefit in others

Researchers to study effectiveness of atorvastatin in preventing heart problems in breast cancer patients

Researchers to study effectiveness of atorvastatin in preventing heart problems in breast cancer patients

New data highlights molecular profiling in guiding treatment of patients with gynecologic malignancies

New data highlights molecular profiling in guiding treatment of patients with gynecologic malignancies

Clinigen Group announces acquisition of SAVENE oncology support therapy from SpePharm

Clinigen Group announces acquisition of SAVENE oncology support therapy from SpePharm

CytRx initiates Phase 3 clinical trial to evaluate efficacy of aldoxorubicin in STS patients

CytRx initiates Phase 3 clinical trial to evaluate efficacy of aldoxorubicin in STS patients

Update Pharma's UPI-928 gets FDA orphan drug designation for AML treatment

Update Pharma's UPI-928 gets FDA orphan drug designation for AML treatment

Study could lead towards a personalised medicine for chemoresistant lymphomata

Study could lead towards a personalised medicine for chemoresistant lymphomata

New drug combination therapy effective for patients with HER2-positive breast cancer

New drug combination therapy effective for patients with HER2-positive breast cancer

Cell Therapeutics presents preclinical study results of PIXUVRI at AACR-NCI-EORTC meeting

Cell Therapeutics presents preclinical study results of PIXUVRI at AACR-NCI-EORTC meeting

Reducing risk factors like hypertension might lower risk of heart disease for childhood survivors

Reducing risk factors like hypertension might lower risk of heart disease for childhood survivors

Cancer patients who receive chest radiation should screen for heart disease every 5-10 years

Cancer patients who receive chest radiation should screen for heart disease every 5-10 years

Cancer patients who receive chest radiation should be screened for heart disease every 5-10 years

Cancer patients who receive chest radiation should be screened for heart disease every 5-10 years

MRI scans of children who have undergone chemotherapy can detect early changes in their hearts

MRI scans of children who have undergone chemotherapy can detect early changes in their hearts

Liposomal anthracycline-based chemotherapy effective for children with leukemia: Study

Liposomal anthracycline-based chemotherapy effective for children with leukemia: Study

Advances in treatment have improved the chances of survival for young patients with cancer

Advances in treatment have improved the chances of survival for young patients with cancer